MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5285-5296

  Ge, Qian ^a   Gérard, Justine ^a   Noël, Laurence ^a   Scroyen, Ilse ^b   Brichard, Sonia M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MICRORNA; MICRORNA 883B; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; INFLAMMATION; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE;

ACUTE-PHASE PROTEINS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; MICRORNAS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84867783362     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1623     Document Type: Article

References (37)

1. de Rooij SR, Nijpels G, Nilsson PM, Nolan JJ, Gabriel R, Bobbioni- Harsch E, Mingrone G, Dekker JM 2009 Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile. Diabetes Care 32:1295-1301
2. Maury E, Brichard SM 2010 Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314:1-16
3. Ouchi N, Walsh K 2007 Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24-30 (Pubitemid 46498041)
4. Chedid P, Hurtado-Nedelec M, Marion-Gaber B, Bournier O, Hayem G, Gougerot-Pocidalo MA, Frystyk J, Flyvbjerg A, El Benna J, Marie JC 2012 Adiponectin and its globular fragment differentially modulate the oxidative burst of primary human phagocytes. Am J Pathol 180:682-692
5. Bauche IB, El Mkadem SA, Pottier AM, Senou M, Many MC, Rezsohazy R, Penicaud L, Maeda N, Funahashi T, Brichard SM 2007 Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation. Endocrinology 148: 1539-1549 (Pubitemid 46457100)
6. Ge Q, Ryken L, Noel L, Maury E, Brichard SM 2011 Adipokines identified as new downstream targets for adiponectin: lessons from adiponectin-overexpressing or -deficient mice. Am J Physiol Endocrinol Metab 301:E326-E335
7. Bartel DP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
8. Guo H, Ingolia NT, Weissman JS, Bartel DP 2010 Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835-840
9. Heneghan HM, Miller N, Kerin MJ 2010 Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11:354-361
10. Hulsmans M, De Keyzer D, Holvoet P 2011 MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25:2515-2527
11. Alexander R, Lodish H, Sun L 2011 MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 15:623-636
12. Strum JC, Johnson JH, Ward J, Xie H, Feild J, Hester A, Alford A, Waters KM 2009 MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol Endocrinol 23:1876-1884
13. Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, Li H, Wang G, Evans AR, Safe S, Wu C, Zhou B 2012 A novel regulator of macrophage activation: miR-223 in obesity associated adipose tissue inflammation. Circulation 125:2892-2903
14. Lijnen HR, Christiaens V, Scroyen I, Voros G, Tjwa M, Carmeliet P, Collen D 2006 Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55:2698-2704 (Pubitemid 44923667)
15. Maury E, Noël L, Detry R, Brichard SM 2009 In vitro hyperresponsiveness to tumor necrosis factor-α contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab 94:1393-1400
16. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, Pascual-Montano A 2009 GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 37:W317-W322
17. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A 2007 GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8:R3
18. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP 2009 Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297:E157-E164
19. Hochberg Y, Benjamini Y 1990 More powerful procedures for multiple significance testing. Stat Med 9:811-818 (Pubitemid 20343989)
20. McGregor RA, Choi MS 2011 microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11:304-316
21. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
22. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA 2006 Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537-541 (Pubitemid 44050158)
23. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clément K 2009 Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94:4619-4623
24. Klöting N, Berthold S, Kovacs P, Schön MR, Fasshauer M, Ruschke K, Stumvoll M, Blüher M 2009 MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 4:e4699
25. Parra P, Serra F, Palou A 2010 Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One 5:e13005
26. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS 2008 Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118:2640-2650 (Pubitemid 351949791)
27. Kopp A, Buechler C, Neumeier M, Weigert J, Aslanidis C, Schölmerich J, Schäffler A 2009 Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 17:648-656
28. Kopp A, Buechler C, Bala M, Neumeier M, Schölmerich J, Schäffler A 2010 Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology 151:1097-1108
29. Villaret A, Galitzky J, Decaunes P, Estève D, Marques MA, Sengenès C, Chiotasso P, Tchkonia T, Lafontan M, Kirkland JL, Bouloumié A 2010 Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59:2755-2763
30. Surmi BK, Hasty AH 2010 The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol 52:27-36
31. Pålsson-McDermott EM, O'Neill LA 2004 Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162 (Pubitemid 39312442)
32. Nakarai H, Yamashita A, Nagayasu S, Iwashita M, Kumamoto S, Ohyama H, Hata M, Soga Y, Kushiyama A, Asano T, Abiko Y, Nishimura F 2012 Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate Immun 18:164-170
33. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772 (Pubitemid 47025442)
34. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747 (Pubitemid 46411051)
35. Sun L, Yu Z, Ye X, Zou S, Li H, Yu D, Wu H, Chen Y, Dore J, Clément K, Hu FB, Lin X 2010 A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925-1932
36. Hulsmans M, Van Dooren E, Mathieu C, Holvoet P 2012 Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PLoS One 7:e32794
37. Asirvatham AJ, Magner WJ, Tomasi TB 2009 miRNA regulation of cytokine genes. Cytokine 45:58-69